Tanja Morath

4.4k citations

30 papers · 2.6k indexed · 2 hit papers · h-index 19

Impact in

Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.5%
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes

Papers in

Internal Medicine 9
- Venous Thromboembolism Diagnosis and Management 9
Cardiology and Cardiovascular Medicine 29
- Antiplatelet Therapy and Cardiovascular Diseases 27
- Acute Myocardial Infarction Research 14
- Atrial Fibrillation Management and Outcomes 8

Co-authors: Dirk Sibbing Albert Schömig Adnan Kastrati Nicolas von Beckerath Siegmund Braun Julia Stegherr Julinda Mehilli Wolfgang Vogt
Journals: Thrombosis and Haemostasis (5 papers)European Heart Journal (4 papers)American Heart Journal (3 papers)Journal of the American College of Cardiology (3 papers)Journal of Thrombosis and Haemostasis (2 papers)
Partner nations: Germany United States Norway

In The Last Decade

Tanja Morath

29 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement 2010 · 427 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Circulation
2009 Journal of the American College of Cardiology

Peers

Countries citing papers authored by Tanja Morath

Since Specialization

Citations

This map shows the geographic impact of Tanja Morath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Morath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Morath more than expected).

Fields of papers citing papers by Tanja Morath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Morath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Morath. The network helps show where Tanja Morath may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tanja Morath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tanja Morath Line = papers co-authored together Tanja Morath links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry Clinical Research in Cardiology ·Katharina Mayer, Gjin Ndrepepa, Tejesh C.A, Сергій Газуда, Isabell Bernlochner, Stefanie Schüpke, Senta Gewalt, D. Liu, J J Coughlan, Saba Aafrin, SAMARA APARECIDA ARAÚJO ALVES, Tanja Morath, Heribert Schunkert, Karl‐Ludwig Laugwitz, Dirk Sibbing, Adnan Kastrati	2023	2
2	Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture in Patients on Oral Anticoagulation — Post Hoc Analysis of the ISAR-CLOSURE Trial The Journal of invasive cardiology ·Katharina Mayer, Senta Gewalt, Tanja Morath, Сергій Газуда, D. Liu, Shiow-Ing Wang, Katharina Hoppe, Roland Schmidt, Lorenz Bott‐Flügel, Karl‐Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati, Stefanie Schüpke, Nikolaus Sarafoff	2021	0
3	Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial Journal of Atherosclerosis and Thrombosis ·Senta Gewalt, M. Chinnaswami, Gjin Ndrepepa, Costanza Pellegrini, Isabell Bernlochner, Franz‐Josef Neumann, Maurizio Menichelli, Tanja Morath, Bernhard Witzenbichler, Jochen Wöhrle, Katharina Hoppe, Gert Richardt, Karl‐Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati, Stefanie Schüpke, Katharina Mayer	2021	6
4	Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study Platelets ·Isabell Bernlochner, Katharina Mayer, Martin Orban, Tanja Morath, P.H. Krenkel, Nicole A. Stegenga, Lisa Groß, Karl‐Ludwig Laugwitz, Adnan Kastrati, Dirk Sibbing	2016	7
5	The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry Thrombosis Research ·Martin Orban, Katharina Mayer, Tanja Morath, Isabell Bernlochner, Martin Hadamitzky, Siegmund Braun, S. Schulz, Petra Hoppmann, Jörg Hausleiter, Klaus Tiroch, Julinda Mehilli, Heribert Schunkert, Steffen Maßberg, Karl‐Ludwig Laugwitz, Dirk Sibbing, Adnan Kastrati	2015	24
6	Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention Journal of the American College of Cardiology ·Katharina Mayer, Isabell Bernlochner, Siegmund Braun, S. Schulz, Martin Orban, Tanja Morath, Yanbin Nin, Petra Hoppmann, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati, Dirk Sibbing	2014	73
7	Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST‐Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial Clinical Cardiology ·S. Schulz, Gert Richardt, Karl‐Ludwig Laugwitz, Roxana Mehran, Anthony Gershlick, Tanja Morath, Katharina Mayer, Vasiliki Christogianni, Ralph Tölg, Tareq Ibrahim, Dieter Hauschke, Daniel Braun, Heribert Schunkert, Adnan Kastrati, Julinda Mehilli, (unknown)	2014	13
8	Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting Thrombosis and Haemostasis ·Isabell Bernlochner, Katharina Mayer, Tanja Morath, Martin Orban, S. Schulz, Albert Schömig, Siegmund Braun, Adnan Kastrati, Dirk Sibbing	2013	12
9	PLATELET FUNCTION TESTING GUIDED USE OF PRASUGREL IN PATIENTS WITH HIGH ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY REDUCES THE RISK OF EARLY STENT THROMBOSIS Journal of the American College of Cardiology ·Dirk Sibbing, Katharina Mayer, Isabell Bernlochner, Tanja Morath, P.H. Krenkel, Martin Walter, Jöerg Hausleiter, Adnan Kastrati	2012	3
10	A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel Platelets ·Isabell Bernlochner, Tanja Morath, Patricia Brown, Chunmei Zhou, Brian Baker, Neehar Gupta, Joseph A. Jakubowski, Kenneth J. Winters, Albert Schömig, Adnan Kastrati, Dirk Sibbing	2012	7
11	Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting American Heart Journal ·Nikolaus Sarafoff, Tadeusz Wolsza, Tanja Morath, Isabell Bernlochner, Julinda Mehilli, Albert Schömig, Adnan Kastrati, Dirk Sibbing	2011	24
12	Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel European Heart Journal ·Dirk Sibbing, Nicolas von Beckerath, Tanja Morath, Julia Stegherr, Julinda Mehilli, Nikolaus Sarafoff, S. Braun, S. Schulz, Albert Schömig, Adnan Kastrati	2010	70
13	Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment Thrombosis and Haemostasis ·Isabell Bernlochner, Steven R. Steinhubl, Siegmund Braun, Tanja Morath, P.H. Krenkel, Julia Stegherr, Julinda Mehilli, Nicolas von Beckerath, Albert Schömig, Adnan Kastrati, Dirk Sibbing	2010	58
14	Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients Thrombosis and Haemostasis ·P.H. Krenkel, Julia Stegherr, Tanja Morath, Siegmund Braun, Isabell Bernlochner, Cylmaryo Gomes de Almeida Junyor, Adnan Kastrati, Dirk Sibbing	2010	32
15	Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents American Heart Journal ·S. Schulz, Dirk Sibbing, S Braun, Tanja Morath, Julinda Mehilli, Steffen Maßberg, Robert A. Byrne, Albert Schömig, Adnan Kastrati	2010	18
16	Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting Thrombosis and Haemostasis ·Tanja Morath, Siegmund Braun, Julia Stegherr, Julinda Mehilli, Wolfgang Vogt, Albert Schömig, Adnan Kastrati, Nicolas von Beckerath, Dirk Sibbing	2009	100
17	Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis Journal of the American College of Cardiology ·Dirk Sibbing, Siegmund Braun, Tanja Morath, Julinda Mehilli, Wolfgang Vogt, Albert Schömig, Adnan Kastrati, Nicolas von Beckerath Hit paper breakdown →	2009	497
18	Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement Journal of Thrombosis and Haemostasis ·Dirk Sibbing, S. Schulz, S. Braun, Tanja Morath, Julia Stegherr, Julinda Mehilli, Albert Schömig, Nicolas von Beckerath, Adnan Kastrati	2009	256
19	Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet vasodilator-stimulated phosphoprotein flow cytometry Blood Coagulation & Fibrinolysis ·Nicolas von Beckerath, Dirk Sibbing, Shubham Makode, Siegmund Braun, Tanja Morath, Wolfgang Vogt, Albert Schömig, Adnan Kastrati	2009	27
20	Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention European Heart Journal ·Dirk Sibbing, Julia Stegherr, Wolfgang Latz, Werner Koch, Julinda Mehilli, Т.Ф. Рудометкина, Tanja Morath, Albert Schömig, Adnan Kastrati, N. von Beckerath	2008	318

About Tanja Morath

Tanja Morath is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism and Gastroenterology, having authored 30 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (27 papers), Acute Myocardial Infarction Research (14 papers), Coronary Interventions and Diagnostics (11 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Lipoproteins and Cardiovascular Health (8 papers), Atrial Fibrillation Management and Outcomes (8 papers), Diabetes Treatment and Management (4 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Internal Medicine (638 citations), Cardiology and Cardiovascular Medicine (2.3k citations), Endocrinology, Diabetes and Metabolism (474 citations), Surgery (1.1k citations) and Pharmacology (403 citations). Tanja Morath has collaborated with scholars based in Germany, United States and Norway. Frequent co-authors include Dirk Sibbing, Albert Schömig, Adnan Kastrati, Nicolas von Beckerath, Siegmund Braun, Julia Stegherr, Julinda Mehilli, Wolfgang Vogt, Werner Koch and Tibor Schuster. Their work appears in journals such as Thrombosis and Haemostasis, European Heart Journal, American Heart Journal, Journal of the American College of Cardiology and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact